BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer

Wei Xia, Satoru Nagase, Amy Gerstein Montia, Sergey M. Kalachikov, Megan Keniry, Tao Su, Lorenzo Memeo, Hanina Hibshoosh, Ramon Parsons

研究成果: Article査読

126 被引用数 (Scopus)

抄録

Screening for tumor suppressor genes in breast cancer revealed multiple truncating mutations of PB1, which encodes the BAF180 subunit of the PBAF chromatin remodeling complex. Mutation was associated with loss of heterozygosity of the wild-type allele. BAF180 complementation of BAF180-mutant tumor cells caused G1 arrest that was dependent on increased expression of the cyclin/cyclin-dependent kinase inhibitor p21/WAF1/CIP1. Endogenous wild-type BAF180 bound to the p21 promoter and was required for proper p21 expression and G1 arrest after transforming growth factor-β and γ-radiation treatment. BAF180 thus functions on two tumor suppressor signaling pathways as a physiologic mediator of p21 expression. We conclude that BAF180 suppresses tumorigenesis, at least in part, through its ability to regulate p21.

本文言語English
ページ(範囲)1667-1674
ページ数8
ジャーナルCancer Research
68
6
DOI
出版ステータスPublished - 2008 3月 15
外部発表はい

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル